Home > Insider Trading > Filing (0001571049-15-010022)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1069899	Phibro Animal Health Corp	PAHC	Pharmaceutical Preparations (2834)	131840497

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1603584	Lee Larry Miller	300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 07666-6712	President, Animal Health	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2015-12-14	23,910	$11.83	23,910	No	4	M	Direct
Class A Common Stock	Disposition	2015-12-14	23,910	$30.74	0	No	4	S	Direct
Class A Common Stock	Acquisiton	2015-12-15	36,090	$11.83	36,090	No	4	M	Direct
Class A Common Stock	Disposition	2015-12-15	36,090	$31.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Option to purchase Class A Common Stock	Disposition	2015-12-14	23,910	$0.00	23,910	$11.83
Class A Common Stock	Option to purchase Class A Common Stock	Disposition	2015-12-15	36,090	$0.00	36,090	$11.83

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
528,590	2012-03-01	2019-02-28	No	4	M	Direct
492,500	2012-03-01	2019-02-28	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2015.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.28 to $31.28, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.61 to $31.29, inclusive.
This amount reflects the aggregate number of options to purchase Class A Common Stock with an expiration date of February 28, 2019 beneficially owned by the Reporting Person. Previously, the Reporting Person reported such options on different rows of Table II based on the applicable Exercisable Date.